TNFα downregulates PPARδ expression in oligodendrocyte progenitor cells: Implications for demyelinating diseases

GLIA

Volumn 41, Issue 1, 2003, Pages 3-14

  Cimini, Annamaria ^a   Bernardo, Antonietta ^b   Cifone, Grazia ^c   Di Muzio, Luisa ^d   Di Loreto, Silvia ^e  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c UNIVERSITY OF L'AQUILA   (Italy)

^d UNIVERSITY OF CHIETI   (Italy)

^e CNR   (Italy)

Author keywords

Cytokines; Demyelinating diseases; Differentiation; Transcriptional factors

Indexed keywords

CERAMIDE; MYELIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLASMALOGEN; SPHINGOSINE ACYLTRANSFERASE; TUMOR NECROSIS FACTOR ALPHA; VERY LONG CHAIN FATTY ACID; CELL RECEPTOR; CYTOKINE; FATTY ACID; GAMMA INTERFERON; LIGNOCERIC ACID; LONG CHAIN FATTY ACID COENZYME A LIGASE; MESSENGER RNA; TRANSCRIPTION FACTOR;

ADRENOLEUKODYSTROPHY; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; DEMYELINATING DISEASE; DISEASE MODEL; FATTY ACID OXIDATION; IMMUNOFLUORESCENCE; IN VITRO STUDY; MULTIPLE SCLEROSIS; MYELINATION; NEWBORN; NONHUMAN; OLIGODENDROGLIA; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; TRANSCRIPTION REGULATION; WESTERN BLOTTING; ANIMAL; CELL CULTURE; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVATION; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; OXIDATION REDUCTION REACTION; PHYSIOLOGY;

ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELLS, CULTURED; CERAMIDES; COENZYME A LIGASES; CYTOKINES; DEMYELINATING DISEASES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; FATTY ACIDS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; INTERFERON TYPE II; OLIGODENDROGLIA; OXIDATION-REDUCTION; RATS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STEM CELLS; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037207510     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/glia.10143     Document Type: Article

References (66)

1. Agresti C, D'Urso D, Levi G. 1996. Reversible inhibitory effects of interferon-γ and tumor necrosis factor-α on oligodendroglial lineage cell proliferation and differentiation in vitro. Eur J Neurosci 8:1106-1116.
2. Agresti C, Bernardo A, Del Russo N, Marziali G, Battistini A, Aloisi F, levi G, Coccia EM. 1998. Synergistic stimulation of MHC class I and IRF-I gene expression by IFN-γ and TNF-α in oligodendrocytes. Eur J Neurosci 10:2975.
3. Arnett HA, Mason J, Marino M, Suzuki K, Matsushima GK, Ting JP-Y. 2001. TNFα promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci 4:1116-1122.
4. Bansal R, Stefansson K, Pfeiffer SE. 1992. Proligodendroblast antigen (POA), a developmental antigen expressed by A007/04-positive oligodendrocyte progenitors prior to the appearance of sulphatide and galactocerebroside. J Neurochem 58:2221-2229.
5. Basu-Modak S, Braissant O, Escher P, Desvergne B, Honegger P, Wahli W. 1999. Peroxisome proliferator-activated receptor beta regulates acyl-CoA synthetase 2 in reaggregated rat brain cultures. J Biol Chem 274:35881-35888.
6. Bernardo A, Levi G, Minghetti L. 2000. Role of the peroxisome proliferator-activated receptor-γ (PPAR-γ) and its natural ligand 15-deoxy-A 12,14-prostaglandin J2 in the regulation of microglial functions. Eur J Neurosci 12:2215-2223.
7. Cammer W. 2000. Effects of TNFα on immature and mature oligodendrocytes and their progenitors in vitro. Brain Res 864:213-219.
8. Campagnoni AT, Macklin WB. 1988. Cellular and molecular aspects of post-trascriptional events in the myelin protein gene expression. Mol Neurol 21:41-89.
9. Cartier N, Lopez I, Moullier P, Rocchiccioli F, Rolland MO, Jorge P, Mosser J, Mandel JL, Bougneres PF, Danos O, Aubourg P. 1995. Retroviral mediated gene transfer corrects very long chain fatty acid metabolism in adrenoleukodystrophy fibroblasts. Proc Natl Acad Sci USA 92:1674-1678.
10. Chang A, Nishiyama A, Peterson J, Prineas, Trapp BD. 2000. NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J Neurosci 20:6404-6412.
11. Chang A, Tourtellotte WW, Rudick R, Trapp BD. 2002. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med 342:199-200.
12. Contreras M, Sengupta TK, Sheikh F, Aubourg P, Singh I. 1997. Topology of ATP-binding domain of adrenoleukodystrophy gene product in peroxisomes. Arch Biochem Biophys 334:369-379.
13. Corton JC, Anderson SP, Stauber A. 2000. Central role of peroxisome proliferator-activated receptors in the action of peroxisome proliferators. Ann Rev Pharmacol Toxicol 40:491-518.
14. Cullingford TE, Bhakoo K, Peuchen S, Dolphin CT, Patel R, Clark JB. 1998. Distribution of mRNAs encoding the peroxisome proliferator-activated receptor alpha, beta, and gamma and the retinoid X receptor alpha, beta, and gamma in rat central nervous system. J Neurochem 70:1366-1375.
15. Dhaunsi GS, Hanevold CD, Singh I. 1994. Impairment of peroxisomal beta-oxidation system by endotoxin treatment. Mol Cell Biochem 135:187-193.
16. Di Biase A, Avellino C, Pieroni F, Quaresima T, Grisolia A, Cappa M, Salvati S. 1997. Effects of exogenous hexacosanoic acid on biochemical myelin composition in weaning and post-weaning rats. Neurochem Res 22:327-331.
17. Dumonteil E, Barrè H, Meissner G. 1994. Effects of palmitoyl carnitine and related metabolites on the avian Ca (2+)-ATPase and Ca (2+) release channel. J Physiol 479:29-39.
18. Faergeman NJ, Knudsen J. 1997. Role of long-chain fatty acyl-CoA esters in the regulation of metabolism in cell signaling. Biochem J 323:1-12.
19. Forman BM, Chen J, Evans RM. 1997. Hypolipidemic drugs, polyunsaturated fatty acids and eicosanoids are ligands for peroxisome proliferator-activated receptors alfa and delta. Proc Natl Acad Sci USA 94:4312-4317.
20. Fulceri R, Gamberucci A, Bellomo G, Giunti R, Benedetti A. 1993. CoA and fatty acyl-CoA derivatives mobilize calcium from a liver reticular pool. Biochem J 295:663-669.
21. Fulceri R, Nori A, Gamberucci A, Volpe P, Giunti R, Benedetti A. 1994. Fatty acyl-CoA esters induce calcium release from terminal cisternae of skeletal muscle. Cell Calcium 15:109-116.
22. Granneman, J, Skoff R, Yang X. 1998. Member of peroxisome proliferator-activated receptor family of transcription factors is differentially expressed by oligodendrocytes. J Neurosci Res 51:563-573.
23. Hewett JA, Hewett SJ, Winkler S, Pfeiffer SE. 1999. Inducible nitric oxide synthase expression in cultures enriched for mature oligodendrocytes is due to microglia. J Neurosci Res 56:189-198.
24. Honegger P. 1985. In: Bottestein JE, Sato G, editors. Cell culture in the neurosciences. New York: Plenum. p 223-243.
25. Isseman I, Green S. 1990. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347:645-649.
26. Jiang C, Ting AT, Seed B. 1998. PPARγ agonists inhibit production of monocyte inflammatory citokines. Nature 391:82-86.
27. Kakar SS, Huang WH, Askari A. 1987. Control of cardiac sodium pump by long-chain coenzymes A. J Biol Chem 262:42-45.
28. Keihoff G, Seidel B, Wolf G. 1998. Absence of nitric oxide synthase in rat oligodendrocytes: a light and electron microscopic study. Acta Histochem 100:409-417.
29. Khan M, Pahan K, Singh AK, Singh I. 1998. Cytokine-induced accumulation of very long-chain fatty acids in rat C6 glial cells: implication for X-adrenoleukodystrophy. J Neurochem 71:78-87.
30. Kliewer SA, Forman BM, Blumberg B, Ong ES, Borgmeyer U, Mangelsdorf DJ, Umesono K, Evans RM. 1994. Differential expresion and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci USA 91:7355-7359.
31. Krey G, Braissant O, Kalkhoven LHFE, Perroud M, Parker MG, Wahli W. 1997. Fatty acids, eicosanoids and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol Endocrinol 11:779-791.
32. Larocca JN, Farooq M, Norton WT. 1997. Induction of oligodendrocyte apoptosis by C2 ceramide. Neurochem Res 22:529-534.
33. Larsson O, Deeney JT, Branstrom R, Berggren PO, Corkey BE. 1996. Activation of the ATP-sensitive K+ channel by long chain acyl-CoA: a role in modulation of pancreatic beta-cell glucose sensitivity. J Biol Chem 271:10623-10626.
34. Levi G, Aloisi F, Wilkin GP. 1987. Differentiation of cerebellar bipotential glial precursors into oligodendrocytes in primary cultures: developmental profile of surface antigens and mitotic activity. J Neurosci Res 18:407-417.
35. Levi, G, Patrizio M, Bernardo A, Petrucci TC, Agresti C. 1993. Human immunodeficiency virus coat protein gp120 inhibits the β-adrenergic regulation of astroglial and microglial functions. Proc Natl Acad Sci USA 90:1541-1545.
36. Lim H, Gupta RA, Ma W, Paria BC, Moller DE, Morrow JD, Dubois RN, Trzaskos JM, Dey SK. 1999. Cyclo-oxigenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARδ. Genes Dev 13:1561-1574.
37. Luck H. 1963. Catalase. In: Bergmayer HU, editor. Methods in enzymatic analysis. New York: Academic Press. p 885-894.
38. Martinez M. 1998. MRI evidence that docosahexaenoic acid ethyl ester improves myelination in generalized peroxisomal disorders. Neurology 51:26-32.
39. Mata de Urquiza A, Liu S, Sjoberg M, Zetterstrom RH, Griffiths W, Sjovall J, Perlmann T. 2000. Docohexanoic acid, a ligand for the retinoid X receptor in mouse brain. Science 290:2140-2144.
40. McGuinness MC, Griffin DE, Raymond GV, Washington CA, Moser HW, Smith KD. 1995. Tumor necrosis factor-α and X-linked adrenoleukodystrophy. J Immunol 61:161-169.
41. McGuinness MC, Powers JM, Bias WB, Schmeckpeper BJ, Segal AH, Gowda VC, Wesselingh SL, Berger J, Griffin DE, Smith KD. 1997. Human leukocyte antigens and cytokine expression in cerebral inflammatory demyelinative lesions ofX-linked adrenoleukodystrophy and multiple sclerosis. J Neuroimmunol 75:174-182.
42. Mitrovich B, Ignarro LJ, Sherman MP, Melinek J, Lane JE. 1994. Nitric oxide as a potential pathological mechanism in demyelination: its differential effects on primary glial cells in vitro. Neuroscience 61:575-585.
43. Moser HW. 1995. Clinical and therapeutic aspects of adrenoleukodystrophy and adrenomyeloneuropathy. J Neuropathol Exp Neurol 54:740-745.
44. Moser HW. 1997. Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy. Brain 120:1485-1508.
45. Natoli G, Costanzo A, Guido F, Moretti F, Bernardo A, Burgio VL, Agresti C, Levrero M. 1998. Nuclear factor KB-independent cytoprotective pathways originating at tumor necrosis factor receptor-associated factor 2. J Biol Chem 273:31262-31272.
46. Pahan K, Sheikh FG, Khan M, Namboodiri AMS, Singh I. 1998. Sphingomyelinase and ceramide stimulate the expression of inducible nitric-oxide synthase in rat primary astrocytes. J Biol Chem 273:2591-2600.
47. Pauken CM, LaBorde JB, Bolon B. 1999. Retinoic acid acts during peri-implantational development to alter axial and brain formation. Anat Embryol 200:645-655.
48. Peters JM, Lee SS, Li W, Ward JM, Gaverilova O, Everett C, Reitman ML, Hudson LD, Gonzalez FJ. 2000. Growth, adipose, brain and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor P. Mol Cell Biol 20:5119-5128.
49. Pombo PM, Barettino D, Ibarrola N, Vega S, Rodriguez-Pena A. 1999. Stimulation of the myelin basic protein gene expression by 9-cisretinoic acid and thyroid hormone: activation in the context of its native promoter. Brain Res Mol Res 64:92-100.
50. Ricote M, Li AC, Wilson TM, Kelly CJ, Glass CK. 1998. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 391:79-82.
51. Rossi A, Kapahi P, Natoli G, Takahashi T, Chen Y, Karin M, Santoro G. 2000. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IKB kinase. Nature 403:103-108.
52. Saluja I, Granneman JG, Skoff R. 2001. PPAR delta agonists stimulate oligodendrocytes differentiation in tissue culture. Glia 33:191-204.
53. Schutgens RHB, Romeyn GJ, Ofman R, van den Bosch H, Tager JM, Wanders RJA. 1986. Acyl-CoA dihydroxy-acetone phosphate acyltransferase in human skin fibroblasts; study of its properties using a new assay method. Biochim Biophys Acta 879:286-291.
54. Selmaj KW, Raine CS. 1988. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 23:339-346.
55. Selmaj KW, Raine CS. 1995. Experimental autoimmune encephalomyelitis: immunotherapy with anti-tumor necrosis factor antibodies and soluble tumor necrosis factor receptors. Neurology 45:S44-S49.
56. Singh I, Moser AE, Goldfisher S, Moser HW. 1984. Lignoceric acid is oxidized in peroxisomes: implication for the Zellweger cerebrohepato-renal syndrome and adrenoleukodystrophy. Proc Natl Acad Sci USA 81:4203-4207.
57. Singh I, Singh R, Bhushan A, Singh AK. 1985. Lignoceroyl-CoA ligase activity in rat brain microsomal fraction: topographical localization and effect of detergents and alpha-cyclodextrin. Arch Biochem Biophys 236:418-426.
58. Vanden Heuvel JP. 1999. Peroxisome proliferator-activated receptors: a critical link among fatty acids, gene expression and carcinogenesis. J Nutr 129:575S-580S.
59. van der Wees J, Schilthuis JG, Koster CH, Diesveld-Schipper H, Folkers GE, van der Saag PT, Dawson MI, Shudo K, van der Burg B, Durston AJ. 1998. Inhibition of retinoic acid receptor-mediated signalling alters positional identity in the developing hindbrain. Development 125:545-556.
60. Vaswani KK, Ledeen RW. 1987. Long-chain acyl-coenzyme A synthetase in rat brain myelin. J Neurosci Res 17:65-70.
61. Wahli W, Braissant O, Devergne B. 1995. Peroxisome proliferator-activated receptors: transcriptional regulators of adipogenesis, lipid metabolism and more. Chem Biol 2:261-266.
62. Wahli W, Michalik L, Kersten S, Tan S, Desvergne B. 2001. Roles of PPAR in energy metabolism and epidermis differentiation. First International Symposium on PPARs, 4-7 April, Florence, Italy.
63. Whitcomb RW, Lineham WM, Knazeck RA. 1988. Effect of long chain saturated fatty acids on membrane microviscosity and adrenocorticotropin responsiveness of human adrenocortical cells in vitro. J Clin Invest 81:185-188.
64. Wolswijk G. 1998. Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocytes precursor cells. J Neurosci 18:601-609.
65. Yang T, Michele DE, Park J, Smart AM, Lin Z, Brosius FC III, Schnerman JB, Briggs JP. 1999. Expression of peroxisomal proliferator-activated receptors and retinoid X receptor in the kidney. Am J Physiol 277:966-973.
66. Yang X, Skoff RP. 1997. Proteolipid protein regulates the survival and differentiation of oligodendrocytes. J Neurosci 17:2056-2070.